Skip to main content

Advertisement

Log in

Recurrence of Cerebral Arteriovenous Malformation Following Complete Obliteration Through Endovascular Embolization

  • Research
  • Published:
Translational Stroke Research Aims and scope Submit manuscript

Abstract

Arteriovenous malformation (AVM) recurrence after embolization was rarely reported. This study aimed to explore the potential risk factors of recurrence in angiographically obliterated AVMs treated with endovascular embolization. This study reviewed AVMs treated with embolization only in a prospective multicenter registry from August 2011 to December 2021, and ultimately included 92 AVMs who had achieved angiographic obliteration. Recurrence was assessed by follow-up digital subtraction angiography (DSA) or magnetic resonance imaging (MRI). Hazard ratios (HRs) with 95% confidence intervals were calculated using Cox proportional hazards regression models. Nineteen AVMs exhibited recurrence on follow-up imaging. The recurrence rates after complete obliteration at 6 months, 1 year, and 2 years were 4.35%, 9.78%, and 13.0%, respectively. Multivariate Cox regression analysis identified diffuse nidus (HR 3.208, 95% CI 1.030–9.997, p=0.044) as an independent risk factor for recurrence. Kaplan–Meier analysis confirmed a higher cumulative risk of recurrence with diffuse nidus (log-rank, p=0.016). Further, in the exploratory analysis of the effect of embolization timing after AVM rupture on recurrence after the complete obliteration, embolization within 7 days of the hemorrhage was found as an independent risk factor (HR 4.797, 95% CI 1.379–16.689, p=0.014). Kaplan–Meier analysis confirmed that embolization within 7 days of the hemorrhage was associated with a higher cumulative risk of recurrence in ruptured AVMs (log-rank, p<0.0001). This study highlights the significance of diffuse nidus as an independent risk factor for recurrence after complete embolization of AVMs. In addition, we identified a potential recurrent risk associated with early embolization in ruptured AVMs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Moftakhar P, Hauptman JS, Malkasian D, Martin NA. Cerebral arteriovenous malformations. Part 1: cellular and molecular biology. Neurosurg Focus. 2009;26:E10. https://doi.org/10.3171/2009.2.FOCUS09316.

    Article  PubMed  Google Scholar 

  2. Richling B, Killer M, Al-Schameri AR, Ritter L, Agic R, Krenn M. Therapy of brain arteriovenous malformations: multimodality treatment from a balanced standpoint. Neurosurgery. 2006;59(5):S3–148. https://doi.org/10.1227/01.NEU.0000237408.95785.64.

    Article  Google Scholar 

  3. Derdeyn CP, Zipfel GJ, Albuquerque FC, Cooke DL, Feldmann E, Sheehan JP, Torner JC. Management of brain arteriovenous malformations: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48:e200–24. https://doi.org/10.1161/STR.0000000000000134.

    Article  PubMed  Google Scholar 

  4. Copelan A, Drocton G, Caton MT, Smith ER, Cooke DL, Nelson J, Abla AA, Fox C, Amans MR, Dowd CF, Halbach VV, Higashida RT, Lawton MT, Kim H, Fullerton HJ, Gupta N, Hetts SW. Brain arteriovenous malformation recurrence after apparent microsurgical cure: increased risk in children who present with arteriovenous malformation rupture. Stroke. 2020;51:2990–6. https://doi.org/10.1161/STROKEAHA.120.030135.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Lang SS, Beslow LA, Bailey RL, Vossough A, Ekstrom J, Heuer GG, Storm PB. Follow-up imaging to detect recurrence of surgically treated pediatric arteriovenous malformations. J Neurosurg Pediatr. 2012;9:497–504. https://doi.org/10.3171/2012.1.PEDS11453.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hak JF, Boulouis G, Kerleroux B, Benichi S, Stricker S, Gariel F, Garzelli L, Meyer P, Kossorotoff M, Boddaert N, Vidal V, Girard N, Dangouloff-Ros V, Brunelle F, Fullerton H, Hetts SW, Blauwblomme T, Naggara O. Pediatric brain arteriovenous malformation recurrence: a cohort study, systematic review and meta-analysis. J Neurointerv Surg. 2022;14:611–7. https://doi.org/10.1136/neurintsurg-2021-017777.

    Article  PubMed  Google Scholar 

  7. Chen CJ, Ding D, Kumar JS, Kearns KN, Ironside N, Yang HC, Ogino A, Kano H, Liscak R, May J, Williams BJ, Gigliotti MJ, Cockroft K, McInerney J, Simon S, Lee CC, Sheehan JP. Hemorrhage and recurrence of obliterated brain arteriovenous malformations treated with stereotactic radiosurgery. Stroke. 2022;53:e363–8. https://doi.org/10.1161/STROKEAHA.122.039213.

    Article  CAS  PubMed  Google Scholar 

  8. Reig AS, Rajaram R, Simon S, Mericle RA. Complete angiographic obliteration of intracranial AVMs with endovascular embolization: incomplete embolic nidal opacification is associated with AVM recurrence. J Neurointerv Surg. 2010;2:202–7. https://doi.org/10.1136/jnis.2009.001636.

    Article  PubMed  Google Scholar 

  9. Chen Y, Han H, Jin H, Meng X, Ma L, Li R, Li Z, Yan D, Zhang H, Yuan K, Wang K. Association of embolization with long-term outcomes in brain arteriovenous malformations: a propensity score-matched analysis using nationwide multicenter prospective registry data. Int J Surg. 2023;109:1900–9. https://doi.org/10.1097/JS9.0000000000000341.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hu J, Albadawi H, Chong BW, Deipolyi AR, Sheth RA, Khademhosseini A, Oklu R. Advances in biomaterials and technologies for vascular embolization. Adv Mater. 2019;31:e1901071. https://doi.org/10.1002/adma.201901071.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Chen Y, Han H, Ma L, Li R, Li Z, Yan D, Zhang H, Yuan K, Wang K, Zhao Y, Zhang Y. Multimodality treatment for brain arteriovenous malformation in Mainland China: design, rationale, and baseline patient characteristics of a nationwide multicenter prospective registry. Chin Neurosurg J. 2022;8:33. https://doi.org/10.1186/s41016-022-00296-y.

    Article  PubMed  PubMed Central  Google Scholar 

  12. AC ARP, Awad IA, Batjer HH, Dowd CF, Furlan A, Giannotta SL, Gomez CR, Gress D, Hademenos G. Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke. 2001;32:1430–42. https://doi.org/10.1161/01.str.32.6.1430.

    Article  Google Scholar 

  13. Spetzler RF, Ponce FA. A 3-tier classification of cerebral arteriovenous malformations. J Neurosurg. 2011;114:842–9. https://doi.org/10.3171/2010.8.JNS10663.

    Article  PubMed  Google Scholar 

  14. Chen Y, Han H, Meng X, Jin H, Gao D, Ma L, Li R, Li Z, Yan D, Zhang H, Yuan K. Development and validation of a scoring system for hemorrhage risk in brain arteriovenous malformations. JAMA Netw Open. 2023;6:e231070. https://doi.org/10.1001/jamanetworkopen.2023.1070.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Jin H, Li Z, Gao D, Chen Y, Han H, Ma L, Yan D, Li R, Li A, Zhang H, Yuan K, Zhang Y, Zhao Y, Meng X, Li Y, Chen X, Wang H, Sun S, Zhao Y. Association of the combined stereotactic radiosurgery and embolization strategy and long-term outcomes in brain arteriovenous malformations with a volume ≤10 mL: a nationwide multicenter observational prospective cohort study. J Neurointerv Surg. 2023; https://doi.org/10.1136/jnis-2023-020289.

  16. Wu EM, El AT, McDougall CM, Aoun SG, Mehta N, Neeley OJ, Plitt A, Shen BV, Sillero R, White JA, Batjer HH, Welch BG. Embolization of brain arteriovenous malformations with intent to cure: a systematic review. J Neurosurg. 2019;132:388–99. https://doi.org/10.3171/2018.10.JNS181791.

    Article  PubMed  Google Scholar 

  17. Yu SC, Chan MS, Lam JM, Tam PH, Poon WS. Complete obliteration of intracranial arteriovenous malformation with endovascular cyanoacrylate embolization: initial success and rate of permanent cure. AJNR Am J Neuroradiol. 2004;25:1139–43.

    PubMed  PubMed Central  Google Scholar 

  18. Mathews MS, Owen CM, Nguyen BV, Kostanian V, Nwagwu CI. Angiographic exclusion of intracranial arteriovenous malformations using onyx(R). Neuroradiol J. 2007;20:711–7. https://doi.org/10.1177/197140090702000616.

    Article  CAS  PubMed  Google Scholar 

  19. Mounayer C, Hammami N, Piotin M, Spelle L, Benndorf G, Kessler I, Moret J. Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol. 2007;28:518–23.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Andreou A, Ioannidis I, Lalloo S, Nickolaos N, Byrne JV. Endovascular treatment of intracranial microarteriovenous malformations. J Neurosurg. 2008;109:1091–7. https://doi.org/10.3171/JNS.2008.109.12.1091.

    Article  PubMed  Google Scholar 

  21. Maimon S, Strauss I, Frolov V, Margalit N, Ram Z. Brain arteriovenous malformation treatment using a combination of Onyx and a new detachable tip microcatheter, SONIC: short-term results. AJNR Am J Neuroradiol. 2010;31:947–54. https://doi.org/10.3174/ajnr.A1959.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. van Rooij WJ, Jacobs S, Sluzewski M, van der Pol B, Beute GN, Sprengers ME. Curative embolization of brain arteriovenous malformations with onyx: patient selection, embolization technique, and results. AJNR Am J Neuroradiol. 2012;33:1299–304. https://doi.org/10.3174/ajnr.A2947.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Jordan JA, Llibre JC, Vazquez F, Rodriguez RM. Predictors of total obliteration in endovascular treatment of cerebral arteriovenous malformations. Neuroradiol J. 2014;27:108–14. https://doi.org/10.15274/NRJ-2014-10013.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Aboukais R, Vinchon M, Quidet M, Bourgeois P, Leclerc X, Lejeune JP. Reappearance of arteriovenous malformations after complete resection of ruptured arteriovenous malformations: true recurrence or false-negative early postoperative imaging result? J Neurosurg. 2017;126:1088–93. https://doi.org/10.3171/2016.3.JNS152846.

    Article  PubMed  Google Scholar 

  25. Ivanov AA, Alaraj A, Charbel FT, Aletich V, Amin-Hanjani S. Recurrence of cerebral arteriovenous malformations following resection in adults: does preoperative embolization increase the risk? Neurosurgery. 2016;78:562–71. https://doi.org/10.1227/NEU.0000000000001191.

    Article  PubMed  Google Scholar 

  26. Klimo PJ, Rao G, Brockmeyer D. Pediatric arteriovenous malformations: a 15-year experience with an emphasis on residual and recurrent lesions. Childs Nerv Syst. 2007;23:31–7. https://doi.org/10.1007/s00381-006-0245-x.

    Article  PubMed  Google Scholar 

  27. Sorenson TJ, Brinjikji W, Bortolotti C, Kaufmann G, Lanzino G. Recurrent brain arteriovenous malformations (AVMs): a systematic review. World Neurosurg. 2018;116:e856–66. https://doi.org/10.1016/j.wneu.2018.05.117.

    Article  PubMed  Google Scholar 

  28. De Leacy R, Ansari SA, Schirmer CM, Cooke DL, Prestigiacomo CJ, Bulsara KR, Hetts SW. Endovascular treatment in the multimodality management of brain arteriovenous malformations: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee. J Neurointerv Surg. 2022;14:1118–24. https://doi.org/10.1136/neurintsurg-2021-018632.

    Article  PubMed  Google Scholar 

  29. Yang D, Wang X, Zhang X, Zhu H, Sun S, Mane R, Zhao X, Zhou J. Temporal evolution of perihematomal blood-brain barrier compromise and edema growth after intracerebral hemorrhage. Clin Neuroradiol. 2023; https://doi.org/10.1007/s00062-023-01285-z.

  30. Sonstein WJ, Kader A, Michelsen WJ, Llena JF, Hirano A, Casper D. Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: an immunocytochemical study. J Neurosurg. 1996;85:838–45. https://doi.org/10.3171/jns.1996.85.5.0838.

    Article  CAS  PubMed  Google Scholar 

  31. Elhammady MS, Heros RC. Editorial: The ARUBA study: where do we go from here? J Neurosurg. 2017;126:481–5. https://doi.org/10.3171/2015.7.JNS151408.

    Article  PubMed  Google Scholar 

  32. Wong J, Slomovic A, Ibrahim G, Radovanovic I, Tymianski M. Microsurgery for ARUBA trial (a randomized trial of unruptured brain arteriovenous malformation)-eligible unruptured brain arteriovenous malformations. Stroke. 2017;48:136–44. https://doi.org/10.1161/STROKEAHA.116.014660.

    Article  PubMed  Google Scholar 

  33. Subat YW, Dasenbrock HH, Gross BA, Patel NJ, Frerichs KU, Du R, Aziz-Sultan MA. Periprocedural intracranial hemorrhage after embolization of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg. 2019;1-11 https://doi.org/10.3171/2019.5.JNS183204.

  34. Vollherbst DF, Chapot R, Bendszus M, Mohlenbruch MA. Glue, Onyx, Squid or PHIL? Liquid embolic agents for the embolization of cerebral arteriovenous malformations and dural arteriovenous fistulas. Clin Neuroradiol. 2022;32:25–38. https://doi.org/10.1007/s00062-021-01066-6.

    Article  PubMed  Google Scholar 

  35. Tailor C, Ashby WS, Gorassini DR, Lownie SP, Walsh K, Pelz D, Hammond RR. Embolized cerebral arteriovenous malformations: a multivariate analysis of 101 excised specimens. J Neurosurg. 2019;132:1140–6. https://doi.org/10.3171/2018.12.JNS182244.

    Article  PubMed  Google Scholar 

  36. Jhaveri A, Amirabadi A, Dirks P, Kulkarni AV, Shroff MM, Shkumat N, Krings T, Pereira VM, Rea V, Muthusami P. Predictive value of MRI in diagnosing brain AVM recurrence after angiographically documented exclusion in children. AJNR Am J Neuroradiol. 2019;40:1227–35. https://doi.org/10.3174/ajnr.A6093.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the patients and neurointerventionists who participated in this study for their help.

Funding

This work was supported by the National Key Research and Development Program of China (Grant No. 2022YFB4702800 to Yuanli Zhao, and No. 2021YFC2501101 and 2020YFC2004701 to Xiaolin Chen), Natural Science Foundation of China (grant no. 81771234 and 82071302 to Yuanli Zhao, and 82202244 to Yu Chen).

Author information

Authors and Affiliations

Authors

Consortia

Contributions

QH and HZ conceptualized and orchestrated the study’s design. HJ, RL, ZL, AL, KY, KW, YZ, QZ, CW, and DY collected the data. YC, HH, LM, and HZ conducted the statistical analysis. HZ wrote the manuscript. HZ, WJ, and YZ assessed the follow-up imaging results. YC, XC, and YZ provided the financial support for the study. YL, SS, XC, and YZ critically scrutinized the manuscript, rendering their invaluable revisions and granting their full approval for the final submission. The others provided valuable comments on the supplement of the scheme design as well as the revision of the draft. All authors reviewed the manuscript. All authors unanimously committed to being accountable for every facet of this work, ensuring the rigorous investigation and resolution of any questions pertaining to its accuracy and integrity.

Corresponding authors

Correspondence to Hao Wang, Yu Chen, Xiaolin Chen or Yuanli Zhao.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Qiang Hao and Haibin Zhang are co-first authors

Supplementary Information

ESM 1

(DOCX 23 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hao, Q., Zhang, H., Han, H. et al. Recurrence of Cerebral Arteriovenous Malformation Following Complete Obliteration Through Endovascular Embolization. Transl. Stroke Res. (2023). https://doi.org/10.1007/s12975-023-01215-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12975-023-01215-8

Keywords

Navigation